The plant will increase production capacity in the country to two billion tablets and capsules a year.
Teva Pharmaceutical Industries Ltd. (NYSE: TEVA; TASE: TEVA) and its Croatian subsidiary, Pliva, opened a new tablets and capsules manufacturing plant in Zagreb on Friday, at an investment of $100 million.
Pliva has hired 200 new employees. Pliva CEO Tihomir Oreskovic said that the plant would expand the company's production capacity. The company's output is exported worldwide.
The new plant will increase Pliva's production capacity by 25% to two billion tablets and capsules a year. Production will begin as soon as the plant obtains US Food and Drug Administration (FDA) and European Medicines Agency (EMEA) certification.
Published by Globes [online], Israel business news - www.globes-online.com - on October 20, 2013
© Copyright of Globes Publisher Itonut (1983) Ltd. 2013